Cargando…
Correlation of Objective Endpoints and Subjective Patient-Reported Outcomes in NAFLD Treatment with Essential Phospholipids: Real-World Data Based on Pooled Analysis of Observational Studies
BACKGROUND: While no “gold-standard” pharmacotherapy for nonalcoholic fatty liver disease (NAFLD) is yet established, essential phospholipids (EPLs) are reported to decrease steatosis and improve laboratory parameters. OBJECTIVE: This analysis evaluated adherence and satisfaction with EPL treatment...
Autores principales: | Ivashkin, Vladimir T., Maevskaya, Marina V., Shirokova, Elena N., Maev, Igor V., Samsonov, Alexey A., Sas, Evgeniy I., Palgova, Liudmila K., Starostin, Kirill |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123926/ https://www.ncbi.nlm.nih.gov/pubmed/33993460 http://dx.doi.org/10.1007/s40801-021-00250-x |
Ejemplares similares
-
Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in Russia
por: Maev, Igor V, et al.
Publicado: (2019) -
Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
por: Maev, Igor V, et al.
Publicado: (2020) -
Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia
por: Maev, Igor V, et al.
Publicado: (2020) -
A New, Non-Invasive Scale for Steatosis Developed Using Real-World Data From Russian Outpatients to Aid in the Diagnosis of Non-Alcoholic Fatty Liver Disease
por: Maev, Igor V., et al.
Publicado: (2020) -
NAFLD and COVID-19: a Pooled Analysis
por: Sachdeva, Sonali, et al.
Publicado: (2020)